La semaglutide ha causato nausea nel 43,9% dei pazienti (16,1% nel placebo), diarrea nel 29,7% (15,9% nel placebo) e vomito nel 24,5% (6,3% nel placebo), secondo il foglio illustrativo di Wegovy
To further characterize metabolic changes, we measured key hormones and biomarkers at the end of the study
Tirzepatide should be avoided by anyone pregnant or planning pregnancy, and its use always belongs under a qualified clinicians supervision
But when it comes to semaglutide and sleep, you can rest easy
Quick Answer: GLP-1 receptor agonists do not directly cause increased urination, as they are not diuretics and polyuria is not a recognised adverse effect